Q-Line Biotec IPO Subscribed 102.42 Times on Day 3
5paisa Capital Ltd
- 2 min read
Last Updated: 25th May 2026 - 05:30 pm
Q-Line Biotec Limited's initial public offering (IPO) closed its three-day subscription window with strong investor interest, reaching 102.42 times overall subscription by 5:10 PM on Day 3 (May 25, 2026). The ₹214.48 crore book-build issue, priced at ₹326 to ₹343 per share, received bids for 42,59,23,600 shares against 41,58,800 shares on offer, with total applications reaching 2,35,644.
Invest in Indian Markets and Unlock Future Potential With 5paisa!Subscription Status of Q-Line Biotec IPO
| Date | QIB (Ex-Anchor) | NII | Individual Investors | Total |
|---|---|---|---|---|
| Day 1 (May 21) | 4.15 | 5.26 | 3.71 | 4.17 |
| Day 2 (May 22) | 5.19 | 15.62 | 10.07 | 9.87 |
| Day 3 (May 25) | 123.94 | 145.98 | 71.44 | 102.42 |
Here are the subscription details for Q-Line Biotec IPO Day 3, as of 4:59 PM:
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (₹ Cr.) |
|---|---|---|---|---|
| Anchor Investors | 1.00 | 17,81,200 | 17,81,200 | 61.10 |
| Market Maker | 1.00 | 3,13,200 | 3,13,200 | 10.74 |
| QIB (Ex-Anchor) | 123.94 | 11,88,000 | 14,72,37,200 | 5,050.24 |
| NII | 145.98 | 8,91,600 | 13,01,53,600 | 4,464.27 |
| Individual Investors | 71.44 | 20,79,200 | 14,85,32,800 | 5,094.68 |
| Total | 102.42 | 41,58,800 | 42,59,23,600 | 14,609.18 |
Key Highlights – Day 3
- Overall subscription surged to 102.42 times on the final day, from Day 2's 9.87 times, driven by a sharp last-day surge across all investor categories.
- Non-institutional investors led at 145.98 times, surging from Day 2's 15.62 times, with bNII at 178.29 times and sNII at 81.35 times, reflecting strong HNI demand for this diagnostics SME IPO.
- Qualified institutional buyers (ex-anchor) surged to 123.94 times from Day 2's 5.19 times, indicating heavy institutional interest concentrated on the closing day.
- Individual investors recorded strong participation at 71.44 times, surging from Day 2's 10.07 times.
Key Highlights – Day 2
- Overall subscription reached 9.87 times, improving from Day 1's 4.17 times.
- Non-institutional investors improved to 15.62 times from Day 1's 5.26 times, with bNII at 17.96 times and sNII at 10.95 times.
- Individual investors improved to 10.07 times from Day 1's 3.71 times.
- Qualified institutional buyers (ex-anchor) improved to 5.19 times from Day 1's 4.15 times.
Key Highlights - Day 1
- Overall subscription reached 4.17 times on Day 1 (May 21, 2026), reflecting strong initial investor interest in this diagnostics SME IPO.
- Non-institutional investors led opening participation at 5.26 times, with bNII at 5.85 times and sNII at 4.08 times on Day 1.
- Qualified institutional buyers (ex-anchor) crossed full subscription at 4.15 times on the opening day.
- Individual investors recorded 3.71 times on Day 1.
- Anchor investors fully subscribed their allocation of ₹61.10 crores on May 20, 2026.
About Q-Line Biotec Limited
Incorporated in 2010, Q-Line Biotec Limited develops, manufactures, and markets diagnostic reagents, kits, point-of-care devices, and consumables, and supplies in-vitro diagnostic equipment for healthcare needs. The company's manufacturing segments include clinical chemistry, haematology, immunodiagnostics, molecular diagnostics, and point-of-care devices, with an annual capacity of approximately 1.4 million kits as of December 31, 2025.
- FREE IPO Application
- Apply with Ease
- Pre-Apply for IPOs
- UPI Bid Instantly
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.